首页 > 最新文献

European Journal of Clinical Microbiology and Infectious Diseases最新文献

英文 中文
A Near Miss of a Retropharyngeal Abscess with MRSA in a 5-Week-Old Boy Due to an Unusual Presentation 一例5周大男孩咽后脓肿合并MRSA,因异常表现而差点漏诊
Pub Date : 2023-07-31 DOI: 10.36519//idcm.2023.241
Amanda J. Bastien, Gene C. Liu, Dennis M. Tang, Abhita Reddy, Kyohei Itamura, Jack Green, Priya R. Soni
A retropharyngeal abscess (RPA) in early childhood is not uncommon due to at-risk lymph nodes in this deep neck space and is typified by fever, odynophagia, and a constellation of respiratory manifestations. However, RPA is exceedingly rare in the neonatal subpopulation and not part of the usual differential diagnosis algorithm in this age range. Herein, we present a unique case of a previously healthy 5-week-old male infant with protracted “congestion” and difficulty in oral feeding, whose clinical course is confounded by intermittent, positional bradycardia and subsequent apnea. He was eventually diagnosed with a methicillin-resistant Staphylococcus aureus (MRSA) RPA, leading to concurrent vascular and airways compromise in the form of baroreceptor-mediated bradycardia from mass-effect carotid body compression. This clinical case is an important reminder that any infant with positional vital sign changes should prompt urgent and thorough investigation for extraordinary and otherwise uncommon pathophysiologic states. The case also highlights the power of multidisciplinary collaboration across multiple specialties and parental advocacy in unifying a diagnosis for rare pediatric illnesses. Keywords: deep neck infections, retropharyngeal abscess, MRSA, positional bradycardia, neonatal infection
儿童早期咽后脓肿(RPA)并不罕见,因为深颈间隙存在高危淋巴结,典型表现为发热、咽痛和一系列呼吸症状。然而,RPA在新生儿亚群中非常罕见,也不是该年龄段通常鉴别诊断算法的一部分。在此,我们报告了一个独特的病例,先前健康的5周大的男婴长期“充血”和口服喂养困难,其临床过程与间歇性,体位性心动过缓和随后的呼吸暂停相混淆。最终诊断为耐甲氧西林金黄色葡萄球菌(MRSA) RPA,质量效应颈动脉体受压导致压力感受器介导的心动过缓,并发血管和气道受损。这个临床病例是一个重要的提醒,任何有体位生命体征改变的婴儿都应该立即进行紧急和彻底的检查,以发现异常或其他不常见的病理生理状态。该病例还强调了跨多个专业的多学科合作和家长倡导在统一罕见儿科疾病诊断方面的力量。关键词:深颈部感染,咽后脓肿,MRSA,体位性心动过缓,新生儿感染
{"title":"A Near Miss of a Retropharyngeal Abscess with MRSA in a 5-Week-Old Boy Due to an Unusual Presentation","authors":"Amanda J. Bastien, Gene C. Liu, Dennis M. Tang, Abhita Reddy, Kyohei Itamura, Jack Green, Priya R. Soni","doi":"10.36519//idcm.2023.241","DOIUrl":"https://doi.org/10.36519//idcm.2023.241","url":null,"abstract":"A retropharyngeal abscess (RPA) in early childhood is not uncommon due to at-risk lymph nodes in this deep neck space and is typified by fever, odynophagia, and a constellation of respiratory manifestations. However, RPA is exceedingly rare in the neonatal subpopulation and not part of the usual differential diagnosis algorithm in this age range. Herein, we present a unique case of a previously healthy 5-week-old male infant with protracted “congestion” and difficulty in oral feeding, whose clinical course is confounded by intermittent, positional bradycardia and subsequent apnea. He was eventually diagnosed with a methicillin-resistant Staphylococcus aureus (MRSA) RPA, leading to concurrent vascular and airways compromise in the form of baroreceptor-mediated bradycardia from mass-effect carotid body compression. This clinical case is an important reminder that any infant with positional vital sign changes should prompt urgent and thorough investigation for extraordinary and otherwise uncommon pathophysiologic states. The case also highlights the power of multidisciplinary collaboration across multiple specialties and parental advocacy in unifying a diagnosis for rare pediatric illnesses. Keywords: deep neck infections, retropharyngeal abscess, MRSA, positional bradycardia, neonatal infection","PeriodicalId":11964,"journal":{"name":"European Journal of Clinical Microbiology and Infectious Diseases","volume":"135 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135315242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fluoroquinolone should be reconsidered as empirical therapy for adult inpatient urinary tract infections in tertiary hospital: a perspective descriptive study from the microbiological and cost-effectiveness aspects 应重新考虑氟喹诺酮作为三级医院成人住院尿路感染的经验性治疗:一项从微生物学和成本效益角度的描述性研究
Pub Date : 2023-05-16 DOI: 10.51559/jcmid.v3i1.47
I Ketut Agus Indra Adhiputra, Marta Setiabudy
Background: Urinary Tract Infections (UTI) has become difficult to treat because of its increasing resistance characteristics to antimicrobial agents, especially to fluoroquinolone. The objective of this study was to describe the effectiveness of fluoroquinolone as empirical therapy for adult inpatient UTI. Methods: This descriptive cross-sectional study was performed at Prof. Dr. I.G.N.G. Ngoerah Hospital, a tertiary Hospital in Denpasar, Bali, from January 2020 until March 2020. All urine specimens were examined using bioMérieux VITEK® 2 System. Result: A total of 155 urine samples met the inclusion and exclusion criteria. We found Escherichia coli (39.4%) as the most common microbes followed by Klebsiella pneumoniae (12.3%). Most of the isolates are multi drug resistant organisms (MDRO) (52.9%) and 57% (49) of the Enterobacteriaceae isolates are extended spectrum beta lactamases (ESBLs). The average duration of the empirical antibiotic therapy was 3.7 days for all fluoroquinolone. Ciprofloxacin (53.5%) is the most common empirical therapy, followed by levofloxacin (16.8%). Antimicrobial sensitivity tests showed that bacteria remained highly sensitive to amikacin (96%) and meropenem (94%). The sensitivity test for ciprofloxacin and levofloxacin was only 26% and 4% respectively. The suitability antibiotic results of fluoroquinolone as empirical therapy were only 20% from 110 isolates. The cost ineffectiveness of fluoroquinolone as empirical therapy is Rp.8,402,400 for 3 months. Conclusion: We concluded that both fluoroquinolone (ciprofloxacin and levofloxacin) have a very low sensitivity rate and are not cost-effective, therefore the use of those antimicrobial agents as empirical therapy should be reconsidered.
背景:尿路感染(UTI)由于其对抗菌药物特别是氟喹诺酮类药物的耐药性增加而变得难以治疗。本研究的目的是描述氟喹诺酮作为经验治疗成人住院尿路感染的有效性。方法:这项描述性横断面研究于2020年1月至2020年3月在巴厘岛登巴萨的三级医院I.G.N.G. Ngoerah医院教授博士进行。所有尿液标本均采用biomrieux VITEK®2系统进行检测。结果:155份尿样符合纳入和排除标准。我们发现大肠杆菌(39.4%)是最常见的微生物,其次是肺炎克雷伯菌(12.3%)。大多数分离株为多重耐药菌(52.9%),57%(49%)的分离株为扩展谱β -内酰胺酶(ESBLs)。所有氟喹诺酮类药物经验性抗生素治疗的平均持续时间为3.7天。环丙沙星(53.5%)是最常见的经验性治疗,其次是左氧氟沙星(16.8%)。抗菌药物敏感性试验显示,细菌对阿米卡星(96%)和美罗培南(94%)高度敏感。环丙沙星和左氧氟沙星的敏感性分别为26%和4%。氟喹诺酮类药物作为经验性药物的适宜性在110株中仅为20%。氟喹诺酮作为经验疗法,3个月的成本无效为8,402,400卢比。结论:氟喹诺酮类药物(环丙沙星和左氧氟沙星)敏感性极低,成本效益不高,应重新考虑将其作为经验性治疗药物。
{"title":"Fluoroquinolone should be reconsidered as empirical therapy for adult inpatient urinary tract infections in tertiary hospital: a perspective descriptive study from the microbiological and cost-effectiveness aspects","authors":"I Ketut Agus Indra Adhiputra, Marta Setiabudy","doi":"10.51559/jcmid.v3i1.47","DOIUrl":"https://doi.org/10.51559/jcmid.v3i1.47","url":null,"abstract":"Background: Urinary Tract Infections (UTI) has become difficult to treat because of its increasing resistance characteristics to antimicrobial agents, especially to fluoroquinolone. The objective of this study was to describe the effectiveness of fluoroquinolone as empirical therapy for adult inpatient UTI. Methods: This descriptive cross-sectional study was performed at Prof. Dr. I.G.N.G. Ngoerah Hospital, a tertiary Hospital in Denpasar, Bali, from January 2020 until March 2020. All urine specimens were examined using bioMérieux VITEK® 2 System. Result: A total of 155 urine samples met the inclusion and exclusion criteria. We found Escherichia coli (39.4%) as the most common microbes followed by Klebsiella pneumoniae (12.3%). Most of the isolates are multi drug resistant organisms (MDRO) (52.9%) and 57% (49) of the Enterobacteriaceae isolates are extended spectrum beta lactamases (ESBLs). The average duration of the empirical antibiotic therapy was 3.7 days for all fluoroquinolone. Ciprofloxacin (53.5%) is the most common empirical therapy, followed by levofloxacin (16.8%). Antimicrobial sensitivity tests showed that bacteria remained highly sensitive to amikacin (96%) and meropenem (94%). The sensitivity test for ciprofloxacin and levofloxacin was only 26% and 4% respectively. The suitability antibiotic results of fluoroquinolone as empirical therapy were only 20% from 110 isolates. The cost ineffectiveness of fluoroquinolone as empirical therapy is Rp.8,402,400 for 3 months. Conclusion: We concluded that both fluoroquinolone (ciprofloxacin and levofloxacin) have a very low sensitivity rate and are not cost-effective, therefore the use of those antimicrobial agents as empirical therapy should be reconsidered.","PeriodicalId":11964,"journal":{"name":"European Journal of Clinical Microbiology and Infectious Diseases","volume":"18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136216340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe case of Streptococcus suis meningitis in Bali Mandara Hospital: a case report 巴厘岛曼达拉医院重症猪链球菌脑膜炎1例报告
Pub Date : 2023-05-16 DOI: 10.51559/jcmid.v3i1.45
I Wayan Agus Gede Manik Saputra, Indira Chadijah Triatmoko, I Gede Eka Widarmawan, I Gede Hermawan, Putu Dwi Adi
Background: Streptococcus suis meningitis (SSM) is one of the zoonotic disease that can cause serious illness in humans. The major risk factor in many cases of SSM is associated with pig husbandry and consuming undercooked pork products. In Indonesia, especially in Bali, the cases of this acute bacterial meningitis has been strongly correlated with consuming Balinese traditional food called “red lawar”, a mixture of raw pork, fresh pork blood and traditional Balinese herbs. This study aims to report a case of SSM in Bali Mandara Hospital. Case description: A 63-year-old man admitted to the Emergency Department because of a decrease in consciousness (Glasgow coma scale 3/15). This patient was transferred from a private hospital with septic shock and suspicious to acute bacterial meningitis. He had other related symptoms like fever, headache, and cough since two days prior to admission. He also had a history of consuming “red lawar” 2 days before the symptoms appeared. Laboratory findings from cerebrospinal fluid analysis and septic marker indicate the patient had bacterial meningitis. The patient was initially started by Meropenem due to his septic shock. The broad spectrum antibiotics were then de-escalate to Ceftriaxone once the culture and sensitivity test completed and yielded Streptococcus suis. The course of Ceftriaxone as definitive therapy has been administered for 14 days and showed clinical improvement without specific sequelae related to SSM infection like hearing loss. Conclusion: Severe meningitis e.c Streptococcus suis leading to septic shock is a life threatening health condition. Adequate antibiotic therapy and multidisciplinary approach can reduce mortality and morbidity of this case.
背景:猪链球菌脑膜炎(SSM)是一种严重的人畜共患疾病。许多SSM病例的主要危险因素与养猪和食用未煮熟的猪肉产品有关。在印度尼西亚,特别是在巴厘岛,这种急性细菌性脑膜炎病例与食用称为“红拉瓦”的巴厘岛传统食物密切相关,这种食物是由生猪肉、新鲜猪肉血和传统巴厘岛草药混合而成。本研究旨在报告一例在巴厘岛曼达拉医院的SSM。病例描述:一名63岁男性因意识下降(格拉斯哥昏迷评分3/15)而入院急诊室。该患者因感染性休克疑似急性细菌性脑膜炎从私立医院转院。入院前2天出现发热、头痛、咳嗽等相关症状。在出现症状前2天,他也有食用"红laww "的历史。脑脊液分析和化脓性标志物的实验室结果表明患者患有细菌性脑膜炎。患者最初因感染性休克而开始使用美罗培南。一旦培养和敏感性试验完成并产生猪链球菌,广谱抗生素就降级为头孢曲松。头孢曲松作为最终治疗疗程14天,临床改善,无SSM感染相关的特异性后遗症,如听力损失。结论:重症脑膜炎如猪链球菌导致的感染性休克是一种危及生命的健康状况。适当的抗生素治疗和多学科联合治疗可降低此病的死亡率和发病率。
{"title":"Severe case of Streptococcus suis meningitis in Bali Mandara Hospital: a case report","authors":"I Wayan Agus Gede Manik Saputra, Indira Chadijah Triatmoko, I Gede Eka Widarmawan, I Gede Hermawan, Putu Dwi Adi","doi":"10.51559/jcmid.v3i1.45","DOIUrl":"https://doi.org/10.51559/jcmid.v3i1.45","url":null,"abstract":"Background: Streptococcus suis meningitis (SSM) is one of the zoonotic disease that can cause serious illness in humans. The major risk factor in many cases of SSM is associated with pig husbandry and consuming undercooked pork products. In Indonesia, especially in Bali, the cases of this acute bacterial meningitis has been strongly correlated with consuming Balinese traditional food called “red lawar”, a mixture of raw pork, fresh pork blood and traditional Balinese herbs. This study aims to report a case of SSM in Bali Mandara Hospital. Case description: A 63-year-old man admitted to the Emergency Department because of a decrease in consciousness (Glasgow coma scale 3/15). This patient was transferred from a private hospital with septic shock and suspicious to acute bacterial meningitis. He had other related symptoms like fever, headache, and cough since two days prior to admission. He also had a history of consuming “red lawar” 2 days before the symptoms appeared. Laboratory findings from cerebrospinal fluid analysis and septic marker indicate the patient had bacterial meningitis. The patient was initially started by Meropenem due to his septic shock. The broad spectrum antibiotics were then de-escalate to Ceftriaxone once the culture and sensitivity test completed and yielded Streptococcus suis. The course of Ceftriaxone as definitive therapy has been administered for 14 days and showed clinical improvement without specific sequelae related to SSM infection like hearing loss. Conclusion: Severe meningitis e.c Streptococcus suis leading to septic shock is a life threatening health condition. Adequate antibiotic therapy and multidisciplinary approach can reduce mortality and morbidity of this case.","PeriodicalId":11964,"journal":{"name":"European Journal of Clinical Microbiology and Infectious Diseases","volume":"61 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136216339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detection of antibacterial activity in chicken meat, eggs, drinking water, animal feed and sewage waste in Tabanan, Bali 巴厘塔巴南地区鸡肉、鸡蛋、饮用水、动物饲料和污水中的抗菌活性检测
Pub Date : 2023-05-16 DOI: 10.51559/jcmid.v3i1.51
Marta Setiabudy, Anak Agung Gede Indraningrat, Putu Arya Suryanditha, Ni Nyoman Sri Budayanti, Ni Komang Semara Yanti, I Ketut Agus Indra Adhiputra, I Gusti Ayu Rai Widowati, Kadek Karang Agustina
Background: The use of antibiotics that are not in accordance with the indications, doses, and duration can trigger resistance and there is concern that it might leave antibiotic residues in the processed product. Aim of this study was to detect the antibacterial activity of livestock products, namely chicken meat and eggs and the surrounding environment such as drinking water, animal feed and waste disposal. This study was a preliminary study before the establishment of antibiotic wise village, One Health approach for antimicrobial stewardship program. Methods: This study was a descriptive study with a cross sectional design to determine antibacterial activity, particularly tetracycline in livestock products and the environment. The research samples were taken from 5 groups of farmers in one of the villages in Tabanan, Bali. Bioassay method based on the Kirby Bauer method was used in this study. Results: From a total of 44 samples, 6 samples showed weak antibiotic tetracycline activity (13.6%), namely in waste disposal (20%) and animal feed (40%). Antibiotic contamination was likely to occur because the animal feed used in this group contains antibiotics with or without the knowledge of the farmers themselves. Disposal waste came from livestock manure that ate the feed or from animal feed that was scattered around the cage. Conclusion: Samples of livestock meat and eggs did not show antibacterial activity. There were samples that have antibiotic activity but weak and inconsistent, namely in samples of waste disposal and animal feed. This condition cannot necessarily be concluded as antibiotic abuse in livestock however it can be the basis for the importance of providing education regarding antimicrobial resistance. Unless there was indication, antibiotics should not be given to livestock on a daily basis.
背景:使用不符合适应症、剂量和持续时间的抗生素可引发耐药性,并可能在加工产品中留下抗生素残留。本研究的目的是检测畜产品(即鸡肉和鸡蛋)及其周围环境(如饮用水、动物饲料和废物处理)的抗菌活性。本研究是建立“抗生素智慧村,同一个健康”抗菌素管理方案前的初步研究。方法:本研究采用横断面设计的描述性研究,以确定抗菌活性,特别是四环素在畜产品和环境中的抗菌活性。研究样本取自巴厘岛塔巴南一个村庄的5组农民。本研究采用Kirby Bauer法进行生物测定。结果:44份样本中,有6份样本四环素活性较弱(13.6%),分别为废弃物处理(20%)和动物饲料(40%)。抗生素污染很可能发生,因为这组动物饲料中含有抗生素,无论农民自己是否知情。处理废物来自吃了饲料的牲畜粪便或散落在笼子周围的动物饲料。结论:禽肉和禽蛋样品不具有抗菌活性。有一些样品具有抗生素活性,但较弱且不一致,即在废物处理和动物饲料样品中。这种情况不能必然归结为牲畜抗生素滥用,但它可以作为提供抗微生物药物耐药性教育的重要性的基础。除非有指示,否则不应每天给牲畜服用抗生素。
{"title":"Detection of antibacterial activity in chicken meat, eggs, drinking water, animal feed and sewage waste in Tabanan, Bali","authors":"Marta Setiabudy, Anak Agung Gede Indraningrat, Putu Arya Suryanditha, Ni Nyoman Sri Budayanti, Ni Komang Semara Yanti, I Ketut Agus Indra Adhiputra, I Gusti Ayu Rai Widowati, Kadek Karang Agustina","doi":"10.51559/jcmid.v3i1.51","DOIUrl":"https://doi.org/10.51559/jcmid.v3i1.51","url":null,"abstract":"Background: The use of antibiotics that are not in accordance with the indications, doses, and duration can trigger resistance and there is concern that it might leave antibiotic residues in the processed product. Aim of this study was to detect the antibacterial activity of livestock products, namely chicken meat and eggs and the surrounding environment such as drinking water, animal feed and waste disposal. This study was a preliminary study before the establishment of antibiotic wise village, One Health approach for antimicrobial stewardship program. Methods: This study was a descriptive study with a cross sectional design to determine antibacterial activity, particularly tetracycline in livestock products and the environment. The research samples were taken from 5 groups of farmers in one of the villages in Tabanan, Bali. Bioassay method based on the Kirby Bauer method was used in this study. Results: From a total of 44 samples, 6 samples showed weak antibiotic tetracycline activity (13.6%), namely in waste disposal (20%) and animal feed (40%). Antibiotic contamination was likely to occur because the animal feed used in this group contains antibiotics with or without the knowledge of the farmers themselves. Disposal waste came from livestock manure that ate the feed or from animal feed that was scattered around the cage. Conclusion: Samples of livestock meat and eggs did not show antibacterial activity. There were samples that have antibiotic activity but weak and inconsistent, namely in samples of waste disposal and animal feed. This condition cannot necessarily be concluded as antibiotic abuse in livestock however it can be the basis for the importance of providing education regarding antimicrobial resistance. Unless there was indication, antibiotics should not be given to livestock on a daily basis.","PeriodicalId":11964,"journal":{"name":"European Journal of Clinical Microbiology and Infectious Diseases","volume":"216 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136216341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of uropathogen producing extended spectrum beta lactamase (ESBL) at urinary tract infection in chronic kidney disease patients 尿路病原体产生扩展谱β -内酰胺酶(ESBL)在慢性肾病患者尿路感染中的流行
Pub Date : 2023-04-21 DOI: 10.51559/jcmid.v3i1.29
Carolin Wijaya, Anselmus Helbert Eriata, I Nengah Tony Rustawan, I Kadek Bayu Adhi Candra, Ni Nyoman Sri Budayanti
Background: Urinary tract infection (UTI) is one of the most common bacterial infections encountered by clinicians in developing countries. UTI in patients with Chronic Kidney Disease (CKD) caused by ESBL-producing gram-negative bacteria has been increased in different countries. The common uropathogenic Gram negative bacteria are Escherichia coli and Klebsiella pneumoniae. The aim of this study was to identify prevalence of the common uropathogen producing ESBL E. coli and K. pneumonia among the patients with urinary tract infection (UTI) in chronic kidney disease as well as the susceptibility of antibiotic therapy. Methods: This was a cross-sectional retrospective study to evaluate clinical urine isolates collected from Prof. Dr. I.G.N.G. Ngoerah Hospital within July 2019 until July 2020. Identification and susceptibility tests in urine isolate were performed by Vitex-2 System (Biomerieux) and interpreted with CLSI 2020 standard. Results: From 1291 urine specimens, 210 urine specimens were collected (29.43%) from patients with UTI in CKD during 12 months. Prevalence of uropathogen in chronic kidney disease from urine specimens were E.coli (41.57%), K.pneumoniae (13.15%), and Pseudomonas aeruginosa (7.36%). It was found that ESBL produced E. coli (56.32%) and also K. pneumoniae (54%). Susceptibility antibiotic E. coli and K. pneumonia of UTI patient with CKD with ESBL producers were meropenem (99,10%), amikacin (98,07%), tigecycline (92,30%), gentamicin (80%), and fosfomycin (79,47%). Conclusion: ESBL producers in patient UTI in CKD patients were E. coli 56,32%, K. pneumoniae 54% that were sensitive to meropenem, amikacin, tigecycline gentamicin, fosfomycin.
背景:尿路感染(UTI)是发展中国家临床医生最常见的细菌感染之一。由产esbl的革兰氏阴性菌引起的慢性肾脏疾病(CKD)患者的尿路感染在不同国家有所增加。常见的尿路致病性革兰氏阴性菌为大肠杆菌和肺炎克雷伯菌。本研究的目的是确定慢性肾脏疾病尿路感染(UTI)患者中常见尿路病原体产生ESBL大肠杆菌和肺炎克雷伯菌的患病率以及抗生素治疗的敏感性。方法:这是一项横断面回顾性研究,评估2019年7月至2020年7月期间在I.G.N.G. Ngoerah医院收集的临床尿液分离物。分离尿液的鉴定和药敏试验采用Vitex-2系统(Biomerieux),并采用CLSI 2020标准进行解释。结果:1291例尿标本中,12个月内收集尿路感染CKD患者尿标本210例(29.43%)。慢性肾脏疾病尿路病原体检出率为大肠杆菌(41.57%)、肺炎克雷伯菌(13.15%)和铜绿假单胞菌(7.36%)。结果发现,ESBL可产生大肠杆菌(56.32%)和肺炎克雷伯菌(54%)。尿路感染合并ESBL的CKD患者的敏感抗生素为:美罗培南(99.10%)、阿米卡星(98.07%)、替加环素(92.30%)、庆大霉素(80%)和磷霉素(79.47%)。结论:CKD患者尿路感染中ESBL产生菌为大肠杆菌56、32%、肺炎克雷伯菌54%,对美罗培南、阿米卡星、替加环素、庆大霉素、磷霉素敏感。
{"title":"Prevalence of uropathogen producing extended spectrum beta lactamase (ESBL) at urinary tract infection in chronic kidney disease patients","authors":"Carolin Wijaya, Anselmus Helbert Eriata, I Nengah Tony Rustawan, I Kadek Bayu Adhi Candra, Ni Nyoman Sri Budayanti","doi":"10.51559/jcmid.v3i1.29","DOIUrl":"https://doi.org/10.51559/jcmid.v3i1.29","url":null,"abstract":"Background: Urinary tract infection (UTI) is one of the most common bacterial infections encountered by clinicians in developing countries. UTI in patients with Chronic Kidney Disease (CKD) caused by ESBL-producing gram-negative bacteria has been increased in different countries. The common uropathogenic Gram negative bacteria are Escherichia coli and Klebsiella pneumoniae. The aim of this study was to identify prevalence of the common uropathogen producing ESBL E. coli and K. pneumonia among the patients with urinary tract infection (UTI) in chronic kidney disease as well as the susceptibility of antibiotic therapy. Methods: This was a cross-sectional retrospective study to evaluate clinical urine isolates collected from Prof. Dr. I.G.N.G. Ngoerah Hospital within July 2019 until July 2020. Identification and susceptibility tests in urine isolate were performed by Vitex-2 System (Biomerieux) and interpreted with CLSI 2020 standard. Results: From 1291 urine specimens, 210 urine specimens were collected (29.43%) from patients with UTI in CKD during 12 months. Prevalence of uropathogen in chronic kidney disease from urine specimens were E.coli (41.57%), K.pneumoniae (13.15%), and Pseudomonas aeruginosa (7.36%). It was found that ESBL produced E. coli (56.32%) and also K. pneumoniae (54%). Susceptibility antibiotic E. coli and K. pneumonia of UTI patient with CKD with ESBL producers were meropenem (99,10%), amikacin (98,07%), tigecycline (92,30%), gentamicin (80%), and fosfomycin (79,47%). Conclusion: ESBL producers in patient UTI in CKD patients were E. coli 56,32%, K. pneumoniae 54% that were sensitive to meropenem, amikacin, tigecycline gentamicin, fosfomycin.","PeriodicalId":11964,"journal":{"name":"European Journal of Clinical Microbiology and Infectious Diseases","volume":"33 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135568798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using ChatGPT in the Medical Field: A Narrative ChatGPT在医学领域的应用:叙述
Pub Date : 2023-03-11 DOI: 10.36519/idcm.2023.227
Ali Peksen, C. Gpt
This text was written by filtering the response of ChatGPT to our querries.ChatGPT has jumped into many fields including the scientific arena. It seems that there could be benefits of this application, however there is a huge area that could be misused. We optimistically focused on the positive sides to inform our readers, and decided to ask ChatGPT to talk about itself.
本文是通过过滤ChatGPT对我们查询的响应而编写的。ChatGPT已经进入了包括科学领域在内的许多领域。这个应用程序似乎有好处,但也有很大的地方可能被滥用。我们乐观地关注积极的一面来告诉我们的读者,并决定让ChatGPT谈谈它自己。
{"title":"Using ChatGPT in the Medical Field: A Narrative","authors":"Ali Peksen, C. Gpt","doi":"10.36519/idcm.2023.227","DOIUrl":"https://doi.org/10.36519/idcm.2023.227","url":null,"abstract":"This text was written by filtering the response of ChatGPT to our querries.\u0000\u0000ChatGPT has jumped into many fields including the scientific arena. It seems that there could be benefits of this application, however there is a huge area that could be misused. We optimistically focused on the positive sides to inform our readers, and decided to ask ChatGPT to talk about itself.","PeriodicalId":11964,"journal":{"name":"European Journal of Clinical Microbiology and Infectious Diseases","volume":"427 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79254588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Prof. Kenan Midilli, MD: Great Virologist, Brilliant Scientist, and Passionate Intellectual (1963-2022) Kenan Midilli教授,医学博士:伟大的病毒学家、杰出的科学家和热情的知识分子(1963-2022)
Pub Date : 2022-12-21 DOI: 10.36519/idcm.2022.201
O. Ergonul
{"title":"Prof. Kenan Midilli, MD: Great Virologist, Brilliant Scientist, and Passionate Intellectual (1963-2022)","authors":"O. Ergonul","doi":"10.36519/idcm.2022.201","DOIUrl":"https://doi.org/10.36519/idcm.2022.201","url":null,"abstract":"","PeriodicalId":11964,"journal":{"name":"European Journal of Clinical Microbiology and Infectious Diseases","volume":"32 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85841249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Unusual Cause of Acute Isolated Hepatitis in a Cancer Patient Post-COVID Pneumonia: HSV-2 新冠肺炎后癌症患者急性分离性肝炎的罕见病因:HSV-2
Pub Date : 2022-09-26 DOI: 10.36519//idcm.2022.117
Türkkan Öztürk-Kaygusuz, A. Sagmak-Tartar, A. Akbulut
{"title":"An Unusual Cause of Acute Isolated Hepatitis in a Cancer Patient Post-COVID Pneumonia: HSV-2","authors":"Türkkan Öztürk-Kaygusuz, A. Sagmak-Tartar, A. Akbulut","doi":"10.36519//idcm.2022.117","DOIUrl":"https://doi.org/10.36519//idcm.2022.117","url":null,"abstract":"","PeriodicalId":11964,"journal":{"name":"European Journal of Clinical Microbiology and Infectious Diseases","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89673087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel SARS-CoV-2 Omicron variants in İstanbul; Rapid Preponderance of BA.2 and BA.5 İstanbul中新型SARS-CoV-2组粒变异BA.2和BA.5快速优势
Pub Date : 2022-09-26 DOI: 10.36519//idcm.2022.143
Yesim Tuyji-Tok, Ebru Yücebag, Ayse Betül Keles, A. Kılınçarslan, O. Nohut, Seda Salman-Yılmaz, M. Kuşkucu, K. Midilli
Objective: In Turkey, the fourth wave of SARS-CoV-2 started in December 2021 and peaked in mid-January 2022. Afterward, peaks were seen in the number of COVID-19 cases because of Omicron BA.2 and BA.5 variants. Our study aimed to observe the prevalence and viral load-re-lated transmissibility rates of the Omicron BA.2 and BA.5 variant infections in our region be-tween January 21 and July 01, 2022, using an easy and cost-effective PCR screening method. Methods: The frequency of BA.2 and BA.5 were determined by the two-stage allele-specific and drop-out RT-PCR method targeting NSP6 105-107del, spike 69-70del, and spike L452R mutation-specific primers. Transmissibility of the Omicron variants was assessed using cycle threshold (Ct) values (a proxy for SARS-CoV-2 viral load and infectivity). Also, using the next generation sequencing (NGS) method, existing mutations were analyzed by generating full-length sequences of the representative, randomly selected samples from the Omicron variants determined by PCR screening test. Results: We defined the first case of BA.2 on January 19, 2022, in İstanbul University-Cerrahpaşa School of Medicine COVID-19 Molecular Diagnosis Laboratory. Following this, it was observed that BA.1 lost its dominance due to the increased transmissibility of BA.2. On May 5, we defined the first case of BA.5, and as of July this Omicron variant rapidly became preponderant, with a frequency of more than 85%. Compared with BA.1, BA.2 and BA.5 were associated with 2.82 (95% CI: 2.33-4.12) and 2.49 (95% CI: 2.16-3.55) fewer cycles, respectively, meaning higher transmissibility. As confirmed by the NGS results, it was concluded that screening with NSP6 105-107del, spike 69-70del and spike L452R mutation targeted PCR method, which is used uniquely in our hospital in Turkey, can be an easy and cost-effective method in the follow-up of Omicron variants. Conclusion: The higher viral load detection in infections with BA.2 and BA.5 reflects a prolonged disease period, and increased transmissibility, so rapid expansion of these Omicron variants in Turkey is inevitable. Even though the prevalence of the Omicron variants in the population can be monitored in near real-time by the PCR screening method, more sequencing studies are needed for the early identification of new mutations that will emerge.
{"title":"Novel SARS-CoV-2 Omicron variants in İstanbul; Rapid Preponderance of BA.2 and BA.5","authors":"Yesim Tuyji-Tok, Ebru Yücebag, Ayse Betül Keles, A. Kılınçarslan, O. Nohut, Seda Salman-Yılmaz, M. Kuşkucu, K. Midilli","doi":"10.36519//idcm.2022.143","DOIUrl":"https://doi.org/10.36519//idcm.2022.143","url":null,"abstract":"Objective: In Turkey, the fourth wave of SARS-CoV-2 started in December 2021 and peaked in mid-January 2022. Afterward, peaks were seen in the number of COVID-19 cases because of Omicron BA.2 and BA.5 variants. Our study aimed to observe the prevalence and viral load-re-lated transmissibility rates of the Omicron BA.2 and BA.5 variant infections in our region be-tween January 21 and July 01, 2022, using an easy and cost-effective PCR screening method. Methods: The frequency of BA.2 and BA.5 were determined by the two-stage allele-specific and drop-out RT-PCR method targeting NSP6 105-107del, spike 69-70del, and spike L452R mutation-specific primers. Transmissibility of the Omicron variants was assessed using cycle threshold (Ct) values (a proxy for SARS-CoV-2 viral load and infectivity). Also, using the next generation sequencing (NGS) method, existing mutations were analyzed by generating full-length sequences of the representative, randomly selected samples from the Omicron variants determined by PCR screening test. Results: We defined the first case of BA.2 on January 19, 2022, in İstanbul University-Cerrahpaşa School of Medicine COVID-19 Molecular Diagnosis Laboratory. Following this, it was observed that BA.1 lost its dominance due to the increased transmissibility of BA.2. On May 5, we defined the first case of BA.5, and as of July this Omicron variant rapidly became preponderant, with a frequency of more than 85%. Compared with BA.1, BA.2 and BA.5 were associated with 2.82 (95% CI: 2.33-4.12) and 2.49 (95% CI: 2.16-3.55) fewer cycles, respectively, meaning higher transmissibility. As confirmed by the NGS results, it was concluded that screening with NSP6 105-107del, spike 69-70del and spike L452R mutation targeted PCR method, which is used uniquely in our hospital in Turkey, can be an easy and cost-effective method in the follow-up of Omicron variants. Conclusion: The higher viral load detection in infections with BA.2 and BA.5 reflects a prolonged disease period, and increased transmissibility, so rapid expansion of these Omicron variants in Turkey is inevitable. Even though the prevalence of the Omicron variants in the population can be monitored in near real-time by the PCR screening method, more sequencing studies are needed for the early identification of new mutations that will emerge.","PeriodicalId":11964,"journal":{"name":"European Journal of Clinical Microbiology and Infectious Diseases","volume":"73 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84267727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Mutant vary region of pncA gene sequence of pyrazinamide resistance among multidrug resistant Mycobacterium tuberculosis isolates 多药耐药结核分枝杆菌吡嗪酰胺耐药pncA基因序列突变区变化
Pub Date : 2022-06-01 DOI: 10.51559/jcmid.v2i1.18
Titiek Sulistyowati, Soedarsono, N. Mertaniasih
ABSTRACTIntroduction: Pyrazinamide (PZA) is one of the potent front-line drugs that act as antituberculosis (antiTB) for nonresistant or resistant Mycobacterium tuberculosis. Mutation of pncA gene is considered to be main target of PZA resistance mechanism. This study aims to determine the mutant gene sequences, location, and correlation of pncA gene mutations with PZA resistance in MDR Mycobacterium tuberculosis as a base for the rapid molecular examination.Objective: This study aims to determine the mutant gene sequence and location of pncA gene with PZA resistance in multidrug resistant (MDR) Mycobacterium tuberculosis need a rapid molecular examination for consideration of MDR TB therapy management in Indonesia.Methods: MDR Mycobacterium tuberculosis were identified and tested for PZA resistance with BACTEC MGIT 960 as a gold standard, followed by DNA extraction, PCR amplification and pncA gene sequencing.Results: An analysis of 561 bp sequence of nucleotides was performed to determine type and location of mutations. A total of 35 isolates of this study showed 14 isolates of pncA gene mutation (40%), and revealed in 13 resistant and 1 sensitive isolate. The correlation analysis of pncA gene mutation to PZA resistance was significant (p = 0,003 and r = 0,452). Mutations in 3 (three) specific regions of pncA gene are 1 isolate at codons 51-76, 1 isolate at codons 130-142, and 3 isolates at codons 163-180.Conclusion: Types of mutations in the pncA gene include substitution of 11 isolates, insertion of 2 isolates, and no deletion. Insertion of 178 CGCGCTGGAGGAGATGCGCACCGCC and multiple mutations in one isolate.
摘要简介:吡嗪酰胺(Pyrazinamide, PZA)是治疗耐药或非耐药结核分枝杆菌的有效一线药物之一。pncA基因突变被认为是PZA耐药机制的主要靶点。本研究旨在确定耐多药结核分枝杆菌中pncA基因突变与PZA耐药的基因序列、位置及相关性,为快速分子检测奠定基础。目的:本研究旨在确定印尼耐多药结核分枝杆菌(MDR) PZA耐药pncA基因突变基因序列及定位,为印尼耐多药结核治疗管理提供快速分子检测参考。方法:以BACTEC MGIT 960为金标准品,鉴定耐多药结核分枝杆菌,进行PZA耐药检测,提取DNA、PCR扩增、pncA基因测序。结果:对561 bp核苷酸序列进行分析,确定突变的类型和位置。本研究共分离35株pncA基因突变14株(40%),耐药13株,敏感1株。pncA基因突变与PZA耐药的相关性分析有统计学意义(p = 0.003, r = 0.0452)。pncA基因的3个特定区域发生突变,密码子51-76处1个,密码子130-142处1个,密码子163-180处3个。结论:pncA基因突变类型包括11个突变株被替换,2个突变株被插入,无缺失。在一个分离物中插入178个CGCGCTGGAGGAGATGCGCACCGCC和多个突变。
{"title":"Mutant vary region of pncA gene sequence of pyrazinamide resistance among multidrug resistant Mycobacterium tuberculosis isolates","authors":"Titiek Sulistyowati, Soedarsono, N. Mertaniasih","doi":"10.51559/jcmid.v2i1.18","DOIUrl":"https://doi.org/10.51559/jcmid.v2i1.18","url":null,"abstract":"ABSTRACT\u0000Introduction: Pyrazinamide (PZA) is one of the potent front-line drugs that act as antituberculosis (antiTB) for nonresistant or resistant Mycobacterium tuberculosis. Mutation of pncA gene is considered to be main target of PZA resistance mechanism. This study aims to determine the mutant gene sequences, location, and correlation of pncA gene mutations with PZA resistance in MDR Mycobacterium tuberculosis as a base for the rapid molecular examination.\u0000Objective: This study aims to determine the mutant gene sequence and location of pncA gene with PZA resistance in multidrug resistant (MDR) Mycobacterium tuberculosis need a rapid molecular examination for consideration of MDR TB therapy management in Indonesia.\u0000Methods: MDR Mycobacterium tuberculosis were identified and tested for PZA resistance with BACTEC MGIT 960 as a gold standard, followed by DNA extraction, PCR amplification and pncA gene sequencing.\u0000Results: An analysis of 561 bp sequence of nucleotides was performed to determine type and location of mutations. A total of 35 isolates of this study showed 14 isolates of pncA gene mutation (40%), and revealed in 13 resistant and 1 sensitive isolate. The correlation analysis of pncA gene mutation to PZA resistance was significant (p = 0,003 and r = 0,452). Mutations in 3 (three) specific regions of pncA gene are 1 isolate at codons 51-76, 1 isolate at codons 130-142, and 3 isolates at codons 163-180.\u0000Conclusion: Types of mutations in the pncA gene include substitution of 11 isolates, insertion of 2 isolates, and no deletion. Insertion of 178 CGCGCTGGAGGAGATGCGCACCGCC and multiple mutations in one isolate.","PeriodicalId":11964,"journal":{"name":"European Journal of Clinical Microbiology and Infectious Diseases","volume":"65 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84754221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
European Journal of Clinical Microbiology and Infectious Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1